In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $10.5 in the prior trading day, AdaptHealth Corp (NASDAQ: AHCO) closed at $10.09, down -3.90%. In other words, the price has decreased by -$3.90 from its previous closing price. On the day, 0.71 million shares were traded. AHCO stock price reached its highest trading level at $10.44 during the session, while it also had its lowest trading level at $9.88.
Ratios:
Our goal is to gain a better understanding of AHCO by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.00 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.41. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 1.08. In the meantime, Its Debt-to-Equity ratio is 1.18 whereas as Long-Term Debt/Eq ratio is at 1.14.
Upgrades & Downgrades
In the most recent recommendation for the company, Jefferies on January 08, 2024, Downgraded its rating to Hold and sets its target price to $8 from $14.50 previously.
On November 08, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $9.50 to $6.50.
Stifel Downgraded its Buy to Hold on May 10, 2023, whereas the target price for the stock was revised from $18 to $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 04 ’25 when Williams David Solomon III sold 5,000 shares for $9.43 per share. The transaction valued at 47,150 led to the insider holds 45,045 shares of the business.
DAVID S WILLIAMS bought 5,000 shares of AHCO for $47,150 on Dec 04 ’25. On Aug 22 ’25, another insider, Williams David Solomon III, who serves as the Director of the company, sold 8,200 shares for $9.73 each. As a result, the insider received 79,786 and left with 50,045 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHCO now has a Market Capitalization of 1366431616 and an Enterprise Value of 3167704064. As of this moment, AdaptHealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.51, and their Forward P/E ratio for the next fiscal year is 10.05. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.42 while its Price-to-Book (P/B) ratio in mrq is 0.85. Its current Enterprise Value per Revenue stands at 0.973 whereas that against EBITDA is 5.009.
Stock Price History:
The Beta on a monthly basis for AHCO is 1.72, which has changed by -0.085222125 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, AHCO has reached a high of $11.63, while it has fallen to a 52-week low of $7.11. The 50-Day Moving Average of the stock is 1.38%, while the 200-Day Moving Average is calculated to be 8.79%.
Shares Statistics:
The stock has traded on average 1.06M shares per day over the past 3-months and 795460 shares per day over the last 10 days, according to various share statistics. A total of 135.42M shares are outstanding, with a floating share count of 89.09M. Insiders hold about 34.21% of the company’s shares, while institutions hold 76.47% stake in the company. Shares short for AHCO as of 1767139200 were 8815109 with a Short Ratio of 8.28, compared to 1764288000 on 9823044. Therefore, it implies a Short% of Shares Outstanding of 8815109 and a Short% of Float of 8.49.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 6.0 analysts currently analyzing and rating the stock of AdaptHealth Corp (AHCO).The consensus estimate for the next quarter is $0.04, with high estimates of $0.08 and low estimates of -$0.0.
Analysts are recommending an EPS of between $0.78 and $0.65 for the fiscal current year, implying an average EPS of $0.71. EPS for the following year is $0.99, with 6.0 analysts recommending between $1.23 and $0.81.
Revenue Estimates
8 analysts predict $832.51M in revenue. The current quarter. It ranges from a high estimate of $852.5M to a low estimate of $817.63M. The current estimate, AdaptHealth Corp’s year-ago sales were $856.64MFor the next quarter, 8 analysts are estimating revenue of $791.08M. There is a high estimate of $800.4M for the next quarter, whereas the lowest estimate is $773.27M.
A total of 8 analysts have provided revenue estimates for AHCO’s current fiscal year. The highest revenue estimate was $3.25B, while the lowest revenue estimate was $3.22B, resulting in an average revenue estimate of $3.23B. In the same quarter a year ago, actual revenue was $3.26BBased on 5 analysts’ estimates, the company’s revenue will be $3.44B in the next fiscal year. The high estimate is $3.45B and the low estimate is $3.4B.
